| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |